Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2019

Oct 11, 2019

34395_dirs_2019-10-11_89f4c682-a93d-40d4-8dce-3928f04badb2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2019-10-09

Reporting Person: Barnes Phillip (Director)

Holdings (Non-Derivative)

Security Shares Ownership
No securities are beneficially owned. 0 Direct